Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.

SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health ...

The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.

On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.

Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.

On Monday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.34 which represents no change from the prior close of $0.34. The stock opened at $0.36 and touched a low of $0.34 ...

All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the ...

NEW YORK (AP) — All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow ...